Home › Compare › BVTEF vs JNJ

BVTEF vs JNJ: Dividend Comparison 2026

BVTEF yields 9389.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BVTEF wins by $29652364190233612.00M in total portfolio value
10 years
BVTEF
BVTEF
● Live price
9389.67%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29652364190233612.00M
Annual income
$29,043,889,991,112,714,000,000.00
Full BVTEF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BVTEF vs JNJ

📍 BVTEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBVTEFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BVTEF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BVTEF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BVTEF
Annual income on $10K today (after 15% tax)
$798,122.07/yr
After 10yr DRIP, annual income (after tax)
$24,687,306,492,445,807,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BVTEF beats the other by $24,687,306,492,445,807,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BVTEF + JNJ for your $10,000?

BVTEF: 50%JNJ: 50%
100% JNJ50/50100% BVTEF
Portfolio after 10yr
$14826182095116806.00M
Annual income
$14,521,944,995,556,357,000,000.00/yr
Blended yield
97.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BVTEF
No analyst data
Altman Z
-12.4
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BVTEF buys
0
JNJ buys
0
No recent congressional trades found for BVTEF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBVTEFJNJ
Forward yield9389.67% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$29652364190233612.00M ✓$20.0K
Annual income after 10y$29,043,889,991,112,714,000,000.00 ✓$827.78
Total dividends collected$29611830854875112.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BVTEF vs JNJ ($10,000, DRIP)

YearBVTEF PortfolioBVTEF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$949,667$938,967.14$10,676$355.77+$939.0K → BVTEF
2$84,353,175$83,337,030.95$11,407$389.39+$84.34M → BVTEF
3$7,008,317,024$6,918,059,127.47$12,198$426.53+$7008.30M → BVTEF
4$544,670,195,710$537,171,296,494.19$13,056$467.62+$544670.18M → BVTEF
5$39,599,349,640,156$39,016,552,530,745.70$13,987$513.12+$39599349.63M → BVTEF
6$2,693,431,305,051,366$2,651,060,000,936,399.50$14,998$563.56+$2693431305.04M → BVTEF
7$171,402,817,083,723,070$168,520,845,587,318,100.00$16,098$619.52+$171402817083.71M → BVTEF
8$10,206,035,765,188,530,000$10,022,634,750,908,946,000.00$17,295$681.69+$10206035765188.51M → BVTEF
9$568,667,475,813,928,340,000$557,747,017,545,176,500,000.00$18,599$750.82+$568667475813928.38M → BVTEF
10$29,652,364,190,233,613,000,000$29,043,889,991,112,714,000,000.00$20,022$827.78+$29652364190233612.00M → BVTEF

BVTEF vs JNJ: Complete Analysis 2026

BVTEF — Stock

Iconic Minerals Ltd., a mineral exploration company, engages in the acquisition and exploration of gold and lithium properties in Nevada and Canada. The company holds a 100% interest in the Hercules project located in Lyon County; and 50% interests in the New Pass project located in Churchill County and Squaw creek property located to the north of Battle Mountain in Nevada. It also holds a 100% interest in the Bonnie Claire property with 1,155 claims covering 13,900 acres located in Nevada; and holds an option to acquire a 100% interest in Smith Creek property located in Nevada. The company was formerly known as Bonaventure Enterprises Inc. and changed its name to Iconic Minerals Ltd. in March 2011. Iconic Minerals Ltd. was incorporated in 1979 and is headquartered in Vancouver, Canada.

Full BVTEF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BVTEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BVTEF vs SCHDBVTEF vs JEPIBVTEF vs OBVTEF vs KOBVTEF vs MAINBVTEF vs ABBVBVTEF vs MRKBVTEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.